(Q50773906)

19 March 2018

title

The heart of the matter: cardiometabolic care in youth with psychosis. (English)

1 reference

19 March 2018

1 reference

Jackie Curtis

1

1 reference

19 March 2018

Hannah D Newall

series ordinal

2

1 reference

19 March 2018

Katherine Samaras

series ordinal

3

1 reference

19 March 2018

publication date

6 January 2012

1 reference

19 March 2018

Early Intervention in Psychiatry: the development, onset and treatment of emerging mental disorders

published in

1 reference

19 March 2018

volume

6

1 reference

19 March 2018

issue

3

1 reference

19 March 2018

page(s)

347-353

1 reference

19 March 2018

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Excess mortality of schizophrenia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Schizophrenia and increased risks of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Effects of exercise on mental and physical health parameters of persons with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Early intervention in psychosis: keeping the body in mind

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00315.X

10.1111/J.1751-7893.2011.00315.X

21 January 2018

Identifiers

DOI

1 reference

19 March 2018

PubMed ID

22221395

1 reference

19 March 2018